Join Akoya Biosciences at Biomarkers & Precision Medicine US 2025
📍 The Westin St. Francis San Francisco on Union Square
335 Powell St, San Francisco, CA 94102, United States
Attend our talk at the conference
Spatial Proteomics for Biomarker Discovery: Mapping Tissue Architecture to Advance Translational Research and Precision Medicine
Monday, October 27, 2025, at 3:25 p.m. PT
Spatial proteomics is transforming translational research by enabling ultrahigh-plex protein phenotyping within intact tissue architecture—critical for biomarker discovery and validation. In this presentation, Clemens Duerrschmid, PhD, will showcase how the PhenoCycler®-Fusion and PhenoImager® HT platforms deliver comprehensive spatial insights across oncology, immunology, and neuroscience. We highlight the successful launch of the PhenoCode Discovery IO60 Human Protein Panel, designed to accelerate immune-oncology research, and preview our soon-to-launch PhenoCode Discovery Human Neuro Panel, expanding spatial biology into neurodegenerative and central nervous system disease applications. Real-world case studies will be used to demonstrate how our platforms bridge the gap between discovery and application, empowering researchers to translate spatial insights into impactful therapeutic strategies for precision medicine.
Presenter
Clemens Duerrschmid, PhD
Manager, Field Applications Scientists at Quanterix and Akoya Biosciences
Visit us at Booth 31
We are excited to bring a team of experts to this conference to connect with you and answer your questions about spatial proteomics and our latest developments.
Expertise on site
Antoinette Ronquillo, MSc
Senior Field Application Scientist at Quanterix and Akoya Biosciences
Clemens Duerrschmid, PhD
Manager, Field Applications Scientists at Quanterix and Akoya Biosciences
Madison Garliepp
Business Development Manager at Quanterix and Akoya Biosciences
Melissa Grigsby
Business Development Manager at Quanterix and Akoya Biosciences
Scott Miller
Senior Marketing Manager at Akoya Biosciences